Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Fluidigm Corp (NASDAQ:FLDM)

8.41
Delayed Data
As of Sep 29
 -0.17 / -1.98%
Today’s Change
4.84
Today|||52-Week Range
12.09
-22.20%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$249.1M

Company Description

Fluidigm Corp. develops, manufactures, and markets microfluidic systems for growth markets such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries. Its proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents that are designed to overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components on a single microfabricated chip. The company was founded by Stephen R. Quake & Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.

Contact Information

Fluidigm Corp.
7000 Shoreline Court
South San Francisco California 94080
P:(650) 266-6000
Investor Relations:
(650) 243-6628

Employees

Shareholders

Mutual fund holders54.53%
Other institutional40.05%
Individual stakeholders3.01%

Top Executives

Gajus Vincent WorthingtonChief Executive Officer & Director
Stephen Christopher LinthwaitePresident & Chief Operating Officer
Vikram JogChief Financial Officer
Marc UngerExecutive VP-Marketing, Research & Development
Jennifer Ling LeePrincipal Accounting Officer, VP & Controller